The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Economic impact of longer treatment duration in first-line for HR+/HER2- metastatic breast cancer: A retrospective analysis.
 
Ibrahim M. Abbass
Employment - Genentech
Stock and Other Ownership Interests - Genentech/Roche; Oncternal Therapeutics
 
Carmen Ng
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Allison Dillon
Employment - Genesis Research
 
Anna Cheng
Employment - Genentech
Stock and Other Ownership Interests - Roche
 
Yolande Du Toit
Employment - Genentech/Roche; Ipsen (I)
Stock and Other Ownership Interests - Genentech/Roche; Ipsen (I)
Travel, Accommodations, Expenses - Genentech/Roche; Ipsen (I)
 
Reva K Basho
Employment - Alignment Healthcare (I); Apollo Medical Holdings (I); Ellison Institute of Technology
Stock and Other Ownership Interests - Alignment Healthcare (I); Apollo Medical Holdings (I); Fresenius (I)
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Pfizer
Speakers' Bureau - Lilly
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst); Takeda (Inst)
Other Relationship - Curio Science; MJH Healthcare Holdings, LLC; WebMD/Medscape
(OPTIONAL) Uncompensated Relationships - AstraZeneca; Genentech; Novartis; Pfizer